- Home
- CELU vs ORIS Comparison
CELU vs ORIS Comparison
Compare CELU & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- ORIS
- Stock Information
- Founded
- CELU 2016
- ORIS 2014
- Country
- CELU United States
- ORIS China
- Employees
- CELU N/A
- ORIS N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- ORIS Farming/Seeds/Milling
- Sector
- CELU Health Care
- ORIS Consumer Staples
- Exchange
- CELU Nasdaq
- ORIS Nasdaq
- Market Cap
- CELU 50.4M
- ORIS 40.5M
- IPO Year
- CELU N/A
- ORIS 2024
- Fundamental
- Price
- CELU $2.30
- ORIS $1.59
- Analyst Decision
- CELU
- ORIS
- Analyst Count
- CELU 0
- ORIS 0
- Target Price
- CELU N/A
- ORIS N/A
- AVG Volume (30 Days)
- CELU 89.6K
- ORIS 2.2M
- Earning Date
- CELU 12-06-2024
- ORIS 02-21-2025
- Dividend Yield
- CELU N/A
- ORIS N/A
- EPS Growth
- CELU N/A
- ORIS N/A
- EPS
- CELU N/A
- ORIS 0.43
- Revenue
- CELU $48,200,000.00
- ORIS $16,745,999.00
- Revenue This Year
- CELU N/A
- ORIS N/A
- Revenue Next Year
- CELU $233.89
- ORIS N/A
- P/E Ratio
- CELU N/A
- ORIS $3.70
- Revenue Growth
- CELU 225.94
- ORIS N/A
- 52 Week Low
- CELU $1.30
- ORIS $1.16
- 52 Week High
- CELU $7.97
- ORIS $56.01
- Technical
- Relative Strength Index (RSI)
- CELU 52.94
- ORIS N/A
- Support Level
- CELU $2.04
- ORIS N/A
- Resistance Level
- CELU $2.39
- ORIS N/A
- Average True Range (ATR)
- CELU 0.17
- ORIS 0.00
- MACD
- CELU 0.02
- ORIS 0.00
- Stochastic Oscillator
- CELU 70.76
- ORIS 0.00
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is a company who is an integrated supplier of tea products in Mainland China. Their major tea products include primarily-processed tea consisting of white tea and black tea, and refined white tea and black tea. Its business operations are vertically integrated, covering cultivation, processing of tea leaves and the sale of tea products to tea business operators (such as wholesale distributors) and end-user retail customers in Mainland China.